CompletedNCT00044616
Fluoxetine and lithium to prevent depression episodes in bipolarity
About this title
Read the official source — NCT00044616Medication studyAges 18–100United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 100 years.
- Listed locations
- PhiladelphiaSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateFebruary 2001
- Recruitment status
- Completed
- Enrollment listed in the registry
- 180
- Sponsor
- University of Pennsylvania
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 100 Years
- Official registry ID
- NCT00044616
- Official title
Show the full official title
Relapse Prevention of Bipolar Type-II Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Philadelphia
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Pennsylvania, a university.
Did this study involve medication?
Yes. The study involved medication, including Fluoxetine and lithium.
Who was this study for?
Listed age limits: 18 years to 100 years.
